Goji Berry Compounds Show Promise as Natural Anti-Aging Therapeutics
New research reveals how polysaccharides from goji berries combat aging through immune support and inflammation reduction.
20 articles
New research reveals how polysaccharides from goji berries combat aging through immune support and inflammation reduction.
New research shows this beneficial gut microbe blocks obesity and improves metabolism through nicotinamide riboside production.
6-methoxykaempferol from sweet cherries restored immune function by 43% and improved beneficial gut bacteria in immunocompromised mice.
A microbiota-derived short-chain fatty acid stops Candida colonization by acidifying fungal cells โ a finding with major implications for immunocompromised patients.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
A microbiome metabolite depleted by antipsychotics protects synapses and cognition โ and supplementing it may reverse the damage.
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
A stem cell intestine model screened 3,500 compounds and flagged glycyrrhizin from black licorice as a top anti-inflammatory candidate for IBD.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
New research reveals how specific gut microbes modify bile acids through hydroxylation, potentially reducing colorectal cancer development.
Enhanced probiotic formula reduces intestinal fibrosis by boosting beneficial bile acids that calm inflammatory responses.
A specific gut bacterium produces deoxycholic acid that hijacks tumor immunity, offering new targets for breast cancer treatment.
Multi-strain probiotics helped maintain symptom relief in GERD patients after discontinuing proton pump inhibitors through gut remodeling.
New real-world evidence reveals timing of hepatitis B treatment depends on infection subtype for optimal outcomes.
Synthetic biology meets the microbiome: designer probiotics restore gut-liver-brain balance better than rifaximin in preclinical models.
New research reveals how certain gut bacteria weaken immune responses against tumors by consuming asparagine, potentially undermining cancer treatments.
A comprehensive JAMA review covers HBV epidemiology, diagnosis, and antivirals that reduce hepatocellular carcinoma risk by ~50%.
Study shows probiotic bacteria shields heart muscle from toxic effects of cancer chemotherapy through metabolite pathway.
Research shows 8 prunes daily outperform medications and fiber supplements for constipation without side effects.